How To Ensure An Unbroken Chain Of Title To Inventions

It is crucial for early-stage life sciences companies to ensure that they have title to the inventions which they rely upon. Firstly, for an early-stage life sciences company to be able to commercialise the products and services it is developing, and to block competitors from offering the same products and services, the company is dependent on the exclusive rights to the inventions that such products and services are based on. Secondly, early-stage life sciences companies are often dependent on obtaining funding through a private placement or IPO. As private placements in, and IPOs of, such companies are investments in the inventions that these companies claim to have, investors will usually conduct due diligence to ensure that such companies have unbroken chains of title to their inventions.